Following natural recovery in adults with spinal cord injury across European centres
Tracks how adults recover over time after a spinal cord injury.
Key facts
- Who runs it
- University of Zurich
- Where
- Zurich, SwitzerlandSee the site
- Trial code
- Registry title
- European Multicentre Study of Human Spinal Cord Injury
- Status
- Recruiting
- People taking part
- 8,000 people, planned
- Started
- Apr 2004
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 25 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with paralysis of the legs or of the arms and legs after a single spinal cord injury or a single loss of blood flow to the spinal cord. It follows how people recover on their own.
- Age
- 18 Years or older
- Sex
- All
- Disease stage
- Paralysis of the legs (paraplegia) or of arms and legs (tetraplegia) from a single injury or a single loss of blood flow (ischemic). The first study check must be possible within 6 weeks after the event.
Main reasons for not taking part
- Paralysis from other causes, such as a slipped disc, tumor, blood vessel malformation (AV-malformation) or spinal cord inflammation (myelitis)
- Known dementia or severely reduced intelligence that limits cooperation or consent
- Nerve damage outside the spinal cord above the level of the injury, such as brachial plexus damage
- Known polyneuropathy (damage to many nerves)
- Severe head and brain injury
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Single event traumatic or ischemic para- or tetraplegia
- First EMSCI assessment possible within the first 6 weeks after incidence
- Patient capable and willing of giving written informed consent
Who cannot take part
- Pre-known dementia or severe reduction of intelligence, leading to reduced capabilities of cooperation or giving consent
- Peripheral nerve lesions above the level of lesion (i.e. plexus brachialis impairment)
- Nontraumatic para- or tetraplegia (i.e. discusprolaps, tumor, AV-malformation, myelitis) excl. single event ischemic incidences
- Pre-known polyneuropathy
- Severe craniocerebral injury
Where in Switzerland
- University of ZurichZurich, SwitzerlandContact: Martin Schubert, MDTaking people
About the trial
What the trial wants to find out
Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge about the natural recovery after spinal cord lesion in a larger population of patients in the sense of a historical control group and to bring new standardised assessment tools to the clinical setting.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- European Multicentre Study of Human SCI
- Plain-language title
- Following natural recovery in adults with spinal cord injury across European centresGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Record updated
- 25 September 2026